Official Title
Assessment of COVID-19 Associated Coagulopathy and Hypercoagulable State in Upper Egypt
Brief Summary

Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most commonly observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation (DIC) compared to 0.6% of survivors.

Detailed Description

studying the detailed coagulation screen and second line coagulation parameters including
both thrombophilia screen and other acute phase coagulation factors.

Completed
Coagulopathy
Eligibility Criteria

Inclusion Criteria:

- patients with COVID 19 positive by RT- PCR

Exclusion Criteria:

- no exclusions

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Egypt
Locations

Assiut University Hospitals
Assiut, Egypt

Assiut University
NCT Number
Keywords
hypercoagulable
Covid-19
MeSH Terms
COVID-19
Hemostatic Disorders
Blood Coagulation Disorders